Home › About Us › Our Staff › Turna Ray

Turna Ray

Senior Editor
Phone Number
+1-212-651-5626
Email
tray@genomeweb.com
Turna Ray at Genomeweb / 360dx Turna Ray at Genomeweb / 360dx

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Dec 06, 2018

Myriad Genetics Describes Advancement of Hispanic-Specific Breast Cancer Polygenic Risk Score

Premium

The studies involved data from 14,000 Hispanic women and showed the 87-SNP risk score outperformed its 86-SNP score for European women.

Dec 04, 2018

Q&A: Gary Marchant Discusses Research on Genetic Testing Lawsuits, Future Liability

Premium

A comprehensive study of genomics malpractice lawsuits showed only a modest increase in recent years, but ASU’s Marchant wouldn't bet on it staying this way in the long term.

Nov 21, 2018

Intermountain to Roll Out Germline Testing for All Newly Diagnosed Cancer Patients in 2019

Premium

Before broad implementation, the healthcare system will gauge the feasibility of the screening program, patient impact, and cost-benefit in a pilot phase.

Nov 15, 2018

FDA, Industry Willing to Collaborate on Dx Regulation via Legislation Despite Differences

Premium

At the Personalized Medicine Conference this week, stakeholders historically at odds over lab test regulation said it is up to Congress to resolve the issue.

Nov 05, 2018

FDA Actions on PGx Testing Confuse Genetic Industry Players

Premium

The genetic testing community is having a tough time deciphering FDA's intentions based on its authorization of 23andMe’s PGx test and a recent safety alert.

Oct 23, 2018

Quest Diagnostics Wrongful Death Lawsuit Ordered to Move to Discovery

Premium

The development is a positive for plaintiff Amy Williams, who has said she hopes her lawsuit will spur greater accountability and transparency among genetic testing labs.

Sep 28, 2018

NorthShore, Ambry Make Prostate Cancer Polygenic Risk Score Available Nationally

Premium

The 72-SNP score is for men of European ancestry who don't have mutations in high penetrance risk genes or mutations in genes associated with aggressive disease.

Sep 11, 2018

Cancer Patient Groups Urge Oregon Committee to Soften Non-Coverage Stance on NGS Panels

An Oregon Health Authority committee issued a draft guidance to not cover NGS testing for solid tumors, which advocacy groups say will limit access to Medicaid beneficiaries.

Aug 24, 2018

MSKCC to Seek CDx Status From FDA for Markers on Cancer NGS Panel

Premium

The move is precipitated by CMS's decision to grant national coverage to NGS companion diagnostics when they're approved by the FDA.

Aug 17, 2018

PGx Experts Encourage Greater Standardization of Tests to Improve Adoption, Patient Care

Premium

Efforts are underway to standardize pharmacogenetic testing, but experts say more needs to be done to encourage broader acceptance of these recommendations.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.